Intraocular concentration of intravenous prednisolone in experimental autoimmune uveoretinitis mice

被引:5
作者
Hashida, Noriyasu
Ohguro, Nobuyuki
Arakawa, Yukio
Kurokawa, Nobuo
Tano, Yasuo
机构
[1] Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Lab Pharmaceut Sci, Suita, Osaka 5650871, Japan
关键词
drug clearance; experimental autoimmune uveoretinitis; pharmacokinetics; prednisolone;
D O I
10.1007/s10384-006-0372-7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
[No abstract available]
引用
收藏
页码:561 / 562
页数:2
相关论文
共 5 条
[1]  
Avichezer D, 2000, INVEST OPHTH VIS SCI, V41, P127
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]   PHARMACOKINETICS OF 3 PREDNISOLONE PRODRUGS - EVIDENCE OF THERAPEUTIC INEQUIVALENCE IN RENAL-TRANSPLANT PATIENTS WITH REJECTION [J].
FREY, BM ;
SEEBERGER, M ;
FREY, FJ .
TRANSPLANTATION, 1985, 39 (03) :270-274
[4]   Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody [J].
Namba, K ;
Ogasawara, K ;
Kitaichi, N ;
Morohashi, T ;
Sasamoto, Y ;
Kotake, S ;
Matsuda, H ;
Iwabuchi, K ;
Iwabuchi, C ;
Ohno, S ;
Onoé, K .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :2962-2969
[5]  
SCHOLES GN, 1985, ARCH OPHTHALMOL-CHIC, V103, P1567